Clinical Trial Update: Effect of Exercise and Phytoestrogen on Bone, Metabolic Syndrome Criteria and Complaints of the Early Menopause [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating exercise and phytoestrogen effects on bone health, metabolic syndrome criteria, and early menopause symptoms was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Metabolic Syndrome
• Osteoporosis

Drugs mentioned

• Phytoestrogen (phytoestrogen)

Snippet

Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Bone Diseases, Metabolic Syndrome X | Phase 3 | Status: TERMINATED